Emerging Treatment Options in Inflammatory Bowel Disease
In Collaboration With
Original Article Reference
This SciPod is a shortened and simplified summary of ‘Emerging Treatment Options in Inflammatory Bowel Disease’, published by Karger Publishers https://doi.org/10.1159/000507782
The complete original works are available at www.karger.com
Share Episode
About this episode
Inflammatory bowel disease (IBD) is a group of gastrointestinal conditions affecting almost 7 million people globally, and this incidence is rising. While treatments have improved over the last century, many patients do not respond sufficiently, especially those with moderate to severe levels of the disease. Novel drugs that restrain the immune system and reduce inflammation are being developed with the hope of improving patient outcomes. Dr Benjamin Misselwitz at Island Hospital of Bern and Bern University and his colleagues have conducted a comprehensive review of the emerging therapies and make recommendations for improving treatment for a wider range of patients.
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
Related episodes
Dr. Rodica Gilca | When Winter Viruses Lost the Calendar
For decades, respiratory viruses seemed to follow a familiar seasonal script. As autumn cooled into winter, influenza returned, respiratory syncytial virus, better known as RSV, filled pediatric wards, and a collection of other viruses circulated alongside them. Hospitals could never predict the season perfectly, but experience provided a rough map of what was coming. Then COVID-19 arrived, and the map stopped matching the territory.
Dr. Kendra Pugh | Mapping the Hidden Geography of Gambling Risk
A lottery ticket is small enough to slip into a pocket, but the forces that shape gambling behavior can stretch across families, neighborhoods, shopping districts, and entire communities. A Massachusetts study led by Dr. Kendra Pugh asks an important but deceptively simple question: when gambling becomes risky or problematic, how much depends on the person, and how much depends on the place?
Dr. Shimaa Ghazal | Reading the Mosquito: What Two New Genomes Can Tell Us About Malaria
A mosquito’s whine is easy to dismiss as a minor irritation. Yet some mosquitoes carry one of humanity’s oldest and deadliest diseases. Malaria is caused by microscopic Plasmodium parasites, but those parasites depend on Anopheles mosquitoes to move from one human host to another. Understanding the mosquito, therefore, is an important part of understanding the disease. Every new genetic reference gives researchers another way to investigate what makes these insects effective vectors, how populations differ, and how their biology may shape transmission. Two recent genome announcements involving Dr. Shimaa Ghazal and student researchers at Phillips Exeter Academy add new genetic resources for studying two particularly important malaria vectors: Anopheles gambiae and Anopheles stephensi.
Dr. Fay Betsou | The Hidden Life of a Biospecimen: Why Better Medical Research Begins Before the Laboratory Assay
To most of us, a vial of blood looks like a simple container of biological truth, a snapshot of what was happening inside a person at the moment the needle entered their arm. Scientists can measure its proteins, read genetic material, hunt for signs of disease, and feed the resulting data into increasingly powerful analytical systems. Yet that vial has a history. How long did it sit before processing? At what temperature? What kind of tube held it? Was it spun, transported, frozen, thawed, or stored? Each step may quietly change what researchers later believe they are seeing.